XML 20 R7.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Losses
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2017   57,564,493        
Balance at beginning of period at Dec. 31, 2017 $ 506,063 $ 737 $ 653,435 $ 98,728 $ (2,385) $ (244,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 21,272     21,272    
Foreign currency translation and other 409       409  
Stock-based compensation (in shares)   380,588        
Stock-based compensation 2,657 $ 6 2,651      
Stock repurchase (5,412)         (5,412)
Equity component of convertible senior notes repurchase (7,830)   (7,830)      
Common stock dividends (4,748)     (4,748)    
Stock option exercises (in shares)   92,473        
Stock option exercises 861 $ 1 860      
Balance at end of period (in shares) at Mar. 31, 2018   58,037,554        
Balance at end of period at Mar. 31, 2018 513,272 $ 744 649,116 115,252 (1,976) (249,864)
Balance at beginning of period (in shares) at Dec. 31, 2017   57,564,493        
Balance at beginning of period at Dec. 31, 2017 506,063 $ 737 653,435 98,728 (2,385) (244,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 57,837          
Foreign currency translation and other (29)          
Balance at end of period (in shares) at Sep. 30, 2018   56,034,243        
Balance at end of period at Sep. 30, 2018 479,887 $ 744 627,348 143,125 (2,445) (288,885)
Balance at beginning of period (in shares) at Mar. 31, 2018   58,037,554        
Balance at beginning of period at Mar. 31, 2018 513,272 $ 744 649,116 115,252 (1,976) (249,864)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 31,902     31,902    
Foreign currency translation and other (644)       (644)  
Stock-based compensation (in shares)   24,040        
Stock-based compensation 2,733   2,733      
Stock repurchase (in shares)   (798,992)        
Stock repurchase (16,001)         (16,001)
Equity component of convertible senior notes repurchase (27,689)   (27,689)      
Common stock dividends (4,407)     (4,407)    
Stock option exercises (in shares)   4,514        
Stock option exercises 49   49      
Balance at end of period (in shares) at Jun. 30, 2018   57,267,116        
Balance at end of period at Jun. 30, 2018 499,215 $ 744 624,209 142,747 (2,620) (265,865)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 4,664     4,664    
Foreign currency translation and other 206       206  
Stock-based compensation 3,088   3,088      
Stock repurchase (in shares)   (1,238,531)        
Stock repurchase (23,020)         (23,020)
Common stock dividends (4,286)     (4,286)    
Unrealized loss on derivative instruments, net of tax (31)       (31)  
Stock option exercises (in shares)   5,658        
Stock option exercises 51   51      
Balance at end of period (in shares) at Sep. 30, 2018   56,034,243        
Balance at end of period at Sep. 30, 2018 479,887 $ 744 627,348 143,125 (2,445) (288,885)
Balance at beginning of period (in shares) at Dec. 31, 2018   55,135,788        
Balance at beginning of period at Dec. 31, 2018 473,849 $ 744 629,039 150,244 (3,343) (302,835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 14,780     14,780    
Foreign currency translation and other 298       298  
Stock-based compensation (in shares)   273,158        
Stock-based compensation 2,586 $ 5 2,581      
Stock repurchase (2,635)         (2,635)
Common stock dividends (4,512)     (4,512)    
Unrealized loss on derivative instruments, net of tax (814)       (814)  
Stock option exercises (in shares)   15,187        
Stock option exercises 54   54      
Balance at end of period (in shares) at Mar. 31, 2019   55,424,133        
Balance at end of period at Mar. 31, 2019 483,606 $ 749 631,674 160,512 (3,859) (305,470)
Balance at beginning of period (in shares) at Dec. 31, 2018   55,135,788        
Balance at beginning of period at Dec. 31, 2018 473,849 $ 744 629,039 150,244 (3,343) (302,835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 71,200          
Foreign currency translation and other (280)          
Balance at end of period (in shares) at Sep. 30, 2019   54,122,624        
Balance at end of period at Sep. 30, 2019 515,058 $ 750 636,756 207,934 (4,895) (325,487)
Balance at beginning of period (in shares) at Mar. 31, 2019   55,424,133        
Balance at beginning of period at Mar. 31, 2019 483,606 $ 749 631,674 160,512 (3,859) (305,470)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 30,960     30,960    
Foreign currency translation and other (115)       (115)  
Stock-based compensation (in shares)   26,639        
Stock-based compensation 2,791   2,791      
Stock repurchase (in shares)   (775,081)        
Stock repurchase (11,217)         (11,217)
Common stock dividends (4,538)     (4,538)    
Unrealized loss on derivative instruments, net of tax 78       78  
Stock option exercises 0          
Balance at end of period (in shares) at Jun. 30, 2019   54,675,691        
Balance at end of period at Jun. 30, 2019 501,565 $ 749 634,465 186,934 (3,896) (316,687)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income for the period 25,460     25,460    
Foreign currency translation and other (463)       (463)  
Stock-based compensation (in shares)   8,176        
Stock-based compensation 1,963   1,985     (22)
Stock repurchase (in shares)   (590,256)        
Stock repurchase (8,778)         (8,778)
Common stock dividends (4,460)     (4,460)    
Unrealized loss on derivative instruments, net of tax (536)       (536)  
Stock option exercises (in shares)   29,013        
Stock option exercises 307 $ 1 306      
Balance at end of period (in shares) at Sep. 30, 2019   54,122,624        
Balance at end of period at Sep. 30, 2019 $ 515,058 $ 750 $ 636,756 $ 207,934 $ (4,895) $ (325,487)